At the 15th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, David Evans talks with UCLA researcher, David Hardy, MD, about the latest data on antiretroviral options for people who are heavily treatment experienced and learns that the treatment landscape has changed radically.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 1 (of 1 total)
Murph, Port Townsend, WA, 2008-02-13 14:22:11
This is such exciting news for those of us who are treatment experienced and resistant to most or all of the existing meds. The feeling of being near the "end of the line" is a scary burden that wears over time, and this sends us a lot of hope. Thanks for sharing the news, POZ!
If you don't understand one of the words in this article,
just double-click it. A window will open with a definition
from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
